Wedgewood Investors’s Pfizer PFE Stock Holding History

Wedgewood Investors’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$261K	Hold	10,842	–	–	0.27%	89
2026 Q1	$304K	Sell	10,842 -414	-4%	-$11K	0.35%	72
2025 Q4	$280K	Buy	11,256 +28	+0.2%	+$706	0.32%	77
2025 Q3	$286K	Sell	11,228 -544	-5%	-$13.4K	0.31%	76
2025 Q2	$285K	Sell	11,772 -421	-3%	-$9.82K	0.33%	78
2025 Q1	$309K	Sell	12,193 -274	-2%	-$7.17K	0.37%	69
2024 Q4	$331K	Sell	12,467 -106	-0.8%	-$2.88K	0.39%	67
2024 Q3	$364K	Buy	12,573 +892	+8%	+$26K	0.4%	64
2024 Q2	$327K	Buy	+11,681	New	+$322K	0.39%	68
2023 Q4	$363K	Sell	12,622 -921	-7%	-$27.8K	0.45%	63
2023 Q3	$449K	Sell	13,543 -825	-6%	-$29.2K	0.61%	49
2023 Q2	$527K	Hold	14,368	–	–	0.68%	45
2023 Q1	$586K	Sell	14,368 -165	-1%	-$7.13K	0.77%	41
2022 Q4	$745K	Buy	14,533 +1,101	+8%	+$52.8K	0.98%	34
2022 Q3	$588K	Sell	13,432 -150	-1%	-$7.29K	0.9%	37
2022 Q2	$712K	Sell	13,582 -50	-0.4%	-$2.55K	1.01%	35
2022 Q1	$706K	Sell	13,632 -100	-0.7%	-$5.19K	0.85%	38
2021 Q4	$811K	Buy	13,732 +329	+2%	+$16.3K	0.96%	33
2021 Q3	$577K	Sell	13,403 -25	-0.2%	-$1.11K	0.75%	40
2021 Q2	$526K	Hold	13,428	–	–	0.66%	47
2021 Q1	$487K	Hold	13,428	–	–	0.61%	48
2020 Q4	$494K	Sell	13,428 -725	-5%	-$26.6K	0.64%	44
2020 Q3	$493K	Hold	14,153	–	–	0.74%	39
2020 Q2	$439K	Buy	14,153 +421	+3%	+$14.3K	0.71%	43
2020 Q1	$425K	Hold	13,732	–	–	0.82%	35
2019 Q4	$510K	Buy	13,732 +159	+1%	+$5.66K	0.73%	42
2019 Q3	$463K	Hold	13,573	–	–	0.69%	44
2019 Q2	$558K	Sell	13,573 -354	-3%	-$14.1K	0.8%	36
2019 Q1	$561K	Buy	13,927 +728	+6%	+$29.2K	0.87%	37
2018 Q4	$547K	Hold	13,199	–	–	1%	34
2018 Q3	$552K	Hold	13,199	–	–	0.87%	38
2018 Q2	$454K	Sell	13,199 -1,327	-9%	-$45.3K	0.78%	44
2018 Q1	$489K	Sell	14,526 -926	-6%	-$31.8K	0.42%	58
2017 Q4	$531K	Sell	15,452 -120	-0.8%	-$4.09K	0.43%	54
2017 Q3	$527K	Hold	15,572	–	–	0.44%	53
2017 Q2	$496K	Sell	15,572 -105	-0.7%	-$3.31K	0.43%	55
2017 Q1	$509K	Sell	15,677 -211	-1%	-$6.65K	0.45%	54
2016 Q4	$490K	Sell	15,888 -316	-2%	-$9.65K	0.45%	54
2016 Q3	$521K	Hold	16,204	–	–	0.49%	49
2016 Q2	$541K	Hold	16,204	–	–	0.51%	48
2016 Q1	$456K	Sell	16,204 -369	-2%	-$10.5K	0.46%	50
2015 Q4	$508K	Hold	16,573	–	–	0.51%	46
2015 Q3	$494K	Hold	16,573	–	–	0.5%	43
2015 Q2	$527K	Hold	16,573	–	–	0.5%	48
2015 Q1	$547K	Sell	16,573 -2,082	-11%	-$66.2K	0.53%	46
2014 Q4	$551K	Buy	18,655 +3,242	+21%	+$93K	0.55%	44
2014 Q3	$432K	Hold	15,413	–	–	0.45%	57
2014 Q2	$434K	Buy	15,413 +422	+3%	+$12K	0.45%	57
2014 Q1	$457K	Sell	14,991 -105	-0.7%	-$3.13K	0.49%	51
2013 Q4	$439K	Sell	15,096 -1,054	-7%	-$30.7K	0.49%	54
2013 Q3	$440K	Sell	16,150 -211	-1%	-$5.74K	0.52%	49
2013 Q2	$435K	Buy	+16,361	New	+$452K	0.56%	48

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Wedgewood Investors's PFE Position: Q2 2026 in Review

Wedgewood Investors held its Pfizer (PFE) position steady in Q2 2026 at 10,842 shares worth $261K. The position accounts for 0.27% of the portfolio, ranked #89.

Wedgewood Investors first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $811K in Q4 2021. 2,823 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Wedgewood Investors held 10,842 shares of Pfizer worth $261K as of Q2 2026.
Wedgewood Investors left its Pfizer share count unchanged in Q2 2026.
Pfizer made up 0.27% of Wedgewood Investors's portfolio in Q2 2026, its #89 holding.
Wedgewood Investors first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
Wedgewood Investors's Pfizer position peaked at $811K in Q4 2021.
2,823 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Wedgewood Investors's 13F filing for Q2 2026, filed 31 Jul 2026.